ELLA Rx

Indications for ELLA:

Prevention of pregnancy following unprotected intercourse or known or suspected contraceptive failure. Not for use as regular contraceptive.

Adult Dose for ELLA:

Take 1 tablet as soon as possible within 120 hrs (5 days) after unprotected intercourse or contraceptive failure. May repeat dose if vomiting occurs within 3 hrs.

Children's Dose for ELLA:

Premenarchal: not applicable.

Pharmacological Class:

Progesterone agonist/antagonist.

Contraindications:

Known/suspected pregnancy (Cat.X).

Warnings/Precautions:

Rule out ectopic pregnancy if lower abdominal pain occurs. Rule out pregnancy if subsequent menses delayed by >1 week. Does not protect against STDs/HIV (AIDS). Postmenopausal women, nursing mothers: not recommended.

Interactions:

Drugs (eg, barbiturates, bosentan, carbamazepine, felbamate, griseofulvin, oxcarbazepine, phenytoin, rifampin, topiramate) or herbals (eg, St. John's wort) that induce certain enzymes (eg, CYP3A4) may decrease effectiveness. May be potentiated by CYP3A4 inhibitors (eg, ketoconazole, itraconazole). May antagonize regular hormonal contraceptives; use barrier contraception for remainder of menstrual cycle. May potentiate P-gp substrates (eg, dabigatran etexilate, digoxin).

Adverse Reactions:

Headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness; menstrual cycle changes.

How Supplied:

Tab—1